Secure Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
VPC
Secure Asset Management's BMRN Position: Q2 2026 in Review
Secure Asset Management increased its BioMarin Pharmaceuticals (BMRN) stake by 11% in Q2 2026, buying an estimated $427K and bringing the position to 78,208 shares worth $4.48M. The position accounts for 0.63% of the portfolio, ranked #42.
Secure Asset Management first reported a position in BMRN in Q1 2026 and has held it in 2 quarters since. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Secure Asset Management held 78,208 shares of BioMarin Pharmaceuticals worth $4.48M as of Q2 2026.
- Secure Asset Management bought 7,788 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $427K.
- BioMarin Pharmaceuticals made up 0.63% of Secure Asset Management's portfolio in Q2 2026, its #42 holding.
- Secure Asset Management first reported a position in BioMarin Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Secure Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.